1. Home
  2. EDSA vs OP Comparison

EDSA vs OP Comparison

Compare EDSA & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • OP
  • Stock Information
  • Founded
  • EDSA 2015
  • OP 2021
  • Country
  • EDSA Canada
  • OP Greece
  • Employees
  • EDSA N/A
  • OP N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • OP
  • Sector
  • EDSA Health Care
  • OP
  • Exchange
  • EDSA Nasdaq
  • OP Nasdaq
  • Market Cap
  • EDSA 6.1M
  • OP 10.5M
  • IPO Year
  • EDSA N/A
  • OP N/A
  • Fundamental
  • Price
  • EDSA $1.73
  • OP $1.09
  • Analyst Decision
  • EDSA Strong Buy
  • OP
  • Analyst Count
  • EDSA 1
  • OP 0
  • Target Price
  • EDSA $21.00
  • OP N/A
  • AVG Volume (30 Days)
  • EDSA 30.8K
  • OP 22.4K
  • Earning Date
  • EDSA 02-07-2025
  • OP 12-20-2024
  • Dividend Yield
  • EDSA N/A
  • OP N/A
  • EPS Growth
  • EDSA N/A
  • OP N/A
  • EPS
  • EDSA N/A
  • OP N/A
  • Revenue
  • EDSA N/A
  • OP $22,098,000.00
  • Revenue This Year
  • EDSA N/A
  • OP N/A
  • Revenue Next Year
  • EDSA N/A
  • OP N/A
  • P/E Ratio
  • EDSA N/A
  • OP N/A
  • Revenue Growth
  • EDSA N/A
  • OP 9.82
  • 52 Week Low
  • EDSA $1.55
  • OP $1.04
  • 52 Week High
  • EDSA $5.99
  • OP $3.15
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 31.51
  • OP 17.26
  • Support Level
  • EDSA $1.73
  • OP $1.04
  • Resistance Level
  • EDSA $1.99
  • OP $1.50
  • Average True Range (ATR)
  • EDSA 0.19
  • OP 0.06
  • MACD
  • EDSA 0.02
  • OP -0.03
  • Stochastic Oscillator
  • EDSA 18.00
  • OP 11.63

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.

Share on Social Networks: